Clinical trial reportOphthalmologyPublished
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results
Regional connection
Verified Author affiliations on the Europe PMC record name Thomas Jefferson University, Wills Eye Hospital. Affiliation source
- Institutions
- Thomas Jefferson University, Wills Eye Hospital
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Ophthalmology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Diabetic Retinopathy; Macular Degeneration; Angiogenesis Inhibitors; Treatment Outcome; Visual Acuity; Wet Macular Degeneration; Intravitreal Injections; Ranibizumab; VEGF; Implant; Age-related macular degeneration
- PubMed ID
- 36870451
- Open access
- Yes, open
- Added to directory
- Source checked